Home/Concerto Biosciences/Cheri Ackerman, PhD

CA

Cheri Ackerman, PhD

Cofounder & Chief Executive Officer

Concerto Biosciences

Therapeutic Areas

Dermatology Infectious Disease Women's Health

Concerto Biosciences Pipeline

Drug	Indication	Phase
CB-0XX	Consumer Skin Health	Pre-clinical
ENS-002 (Fermata Derm)	Atopic Dermatitis	Pre-clinical
ENS-003	Vaginal Yeast Infections	Pre-clinical

Leadership Team at Concerto Biosciences

Jared Kehe, PhD

Cofounder & Chief Scientific Officer

Bernardo Cervantes, PhD

Cofounder & Chief Operating Officer

Chief Financial Officer

Lou Vaickus, MD

Interim Chief Medical Officer

View full Concerto Biosciences profile